Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 275 de 412 resultados encontrados
Opções avançadas
Data de publicação: 14/04/2021 - 18:22
Many viruses can hamper coagulation, including those that cause dengue fever and yellow fever. In more severe cases, they may lead to bleeding. This is why these diseases are considered hemorrhagic viral fevers. In a paper recently published in the science magazine “Memórias do Instituto Oswaldo Cruz”, a group of ten researchers argues that the new coronavirus (SARS-CoV-2) should be the first agent recognized as acting in the...
Notícias
Data de publicação: 12/04/2021 - 12:42
A methodology that aims to make the monitoring of the new coronavirus variants simpler and faster, besides being cheaper, has just been developed at Fiocruz Pernambuco. It is based on a technique that is already widely used and available in Brazil and in the world, the Sanger sequencing - also called sequencing by capillary electrophoresis. The article with this finding has just been made available online as a preprint on the MedRxiv platform....
Notícias
Data de publicação: 09/04/2021 - 09:08
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates. (Photo:Isabela Carrari -...
Notícias
Data de publicação: 06/04/2021 - 09:24
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to...
Notícias
Data de publicação: 01/04/2021 - 10:02
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups. The first group includes urgent measures that involve the containment of the...
Notícias
Data de publicação: 26/03/2021 - 14:14
Autoras: Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham. Publicação original em inglês.  Confira mais informações no Observatório Covid-19. Acesse o especial da Fiocruz sobre a Covid-19.
Documento/Arquivo
Data de publicação: 26/03/2021 - 11:50
Science formulated with collaboration and transparency. On March 17th, the Oswaldo Cruz Foundation (Fiocruz) presented the advances in the implantation of the Institutional Data Repository for Research - Arca Dados, an important element to implement the Policy for Management, Sharing and Opening of Data for Research. The document (approved in September 2020 by the Deliberative Council of Fiocruz and whose Ordinance came into term in December) is...
Notícias
Data de publicação: 18/03/2021 - 13:30
The United Kingdom ambassador in Brazil, Peter Wilson, visited the Oswaldo Cruz Foundation (Fiocruz) on March 5 for a meeting with the president of the institution, Nísia Trindade Lima, and to visit the Immunobiological Technology Institute (Bio-Manguinhos) plant that is producing the Covid-19 Fiocruz vaccine. Photo: Pedro Paulo Gonçalves “I greatly admire the work you have you been doing, and we are here to know...
Notícias
Data de publicação: 17/03/2021 - 09:46
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil. The Bulletin shows that, at the moment, of the...
Notícias
Data de publicação: 15/03/2021 - 11:54
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the...
Notícias
Data de publicação: 12/03/2021 - 11:49
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese)....
Notícias
Data de publicação: 10/03/2021 - 18:21
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and...
Notícias
Data de publicação: 10/03/2021 - 12:53
Many affluent countries, with the necessary technological capabilities and expertise, entered into the production of Covid-19 vaccines or sought the biopharmaceutical companies to block them for themselves through anticipated buying. It is estimated that as early December 2020, 3.8 billion vaccine doses had been guaranteed to these countries by several producers. If one compares that figure with the 3.2 billion doses, that include the 700...
Notícias
Data de publicação: 08/03/2021 - 10:01
A pioneering study used the genomic sequencing of samples of Mycobacterium tuberculosis to assess the resistance of indigenous peoples to anti-tuberculosis drugs. Published on Scientific Reports, a magazine of the Nature group, the research also revealed a high frequency of polymorphisms associated with resistance to the main drugs used in the treatment. The article, titled Identification of a predominant genotype of...
Notícias
Data de publicação: 25/02/2021 - 13:22
The Fiocruz Genomic Network is participating in a project by the Ministry of Health that will sequence new coronavirus samples throughout the national territory. Currently, only three central laboratories (Lacens) in the states are capable of this task. The Network brings together researchers from various institutes of the Foundation to study genetics and genomes of viruses, bacteria, fungi, parasites, and humans, in addition to receiving...
Notícias
Data de publicação: 25/02/2021 - 11:42
On February 5, the Ministry of Health (MoH) and Fiocruz launched a public notice for the construction of the Industrial Complex of Biotechnology in Health (Cibs, in the Portuguese acronym). The document opens a bidding process for hiring investors interested in participating in the construction of a new complex of the Immunobiological Technology Institute of the Oswaldo Cruz Foundation (Bio-Manguinhos/Fiocruz), in Santa Cruz, in Rio de Janeiro....
Notícias
Data de publicação: 05/02/2021 - 10:57
A project of Fiocruz Pernambuco was selected in a public call released by the Federal Government in a partnership with other countries that are part of BRICS - formed by Brazil, Russia, India, China and South Africa. The public notice’s resources had R$6.2 million provided by the Ministry of Science, Technology and Innovation and R$1 million provided byt the Ministry of Health to fund researches directed to facing the Covid-19 pandemic...
Notícias
Data de publicação: 05/02/2021 - 10:19
On the side of Maici river (Aldeia Dudu), an indigenous woman called Potai Pirahã received the first dose of the Covid-19 vaccine. Aftere 28 days, she should get the second dose. Potai Pirahã is part of a group of 713 indigenous people that will be vaccinated in the municipality of Humaitá (in the South of Amazonas). The vaccination in indigenous lands of the area started on January 26th, along with lectures to raise...
Notícias
Data de publicação: 05/02/2021 - 10:09
On January 29th, Fiocruz officially submited the application to register the Covid-19 vaccine to the Healthy Surveillance Agency (Anvisa), which will allow the Oxford-AstraZeneca immunizer Covid-19 vaccine across the country. “This is another key step in facing the pandemic and it will allow the Brazilian population to have broad access to the vaccine, which will be distributed through the Ministry of Health’s National Immunization...
Notícias
Data de publicação: 03/02/2021 - 12:41
Gender & Covid-19: How to create a genderresponsive pandemic plan - Addressing the secondary effects of COVID-19 (documento em ingês) Autores: Erica N. Rosser, Rosemary Morgan, Heang-Lee Tan, Kate Hawkins, Anne Ngunjiri, Amy Oyekunle, Brunah Schall, Denise Nacif Pimenta, Eduardo Tamaki, Mariela Rocha, Clare Wenham. Confira mais informações no Observatório Covid-19. Acesse o especial da Fiocruz...
Documento/Arquivo
Data de publicação: 25/01/2021 - 12:46
Analyzing the characteristics of patients hospitalized due to Covid-19 in Brazil and examining the impact of the disease in the use of resources and in hospital mortality were the goals of the study that assessed the first 250 thousand hospitalizations due to Covid-19 in Brazil, between February 16 and August 15, 2020. “The work has two great contributions to give: documenting the effect of the epidemic on the Brazilian population and on...
Notícias
Data de publicação: 19/01/2021 - 16:06
Preservation Policy Scientific and cultural collections of Fiocruz
Documento/Arquivo
Data de publicação: 18/12/2020 - 14:24
Representatives of Fiocruz and of the British Embassy met on December 15 to discuss cooperation in health between the Foundation and institutions of the United Kingdom. At the meeting, requested by the embassy’s business manager, Liv Davidson, and with the presence of the British consul in Rio de Janeiro, Simon Wood, the attendees discussed current partnerships and possible new ones. The main cooperation of Fiocruz with British...
Notícias
Data de publicação: 17/12/2020 - 16:11
At the Ordinary General Assembly held on December 3, the Board of Directors of the Brazilian Academy of Sciences (ABC, in the Portuguese acronym) released the results of the elections to full members, correspondents, employees, and affiliates. The president of Fiocruz, Nísia Trindade Lima, was elected a full member in the Social Sciences category. And researcher Milena Botelho Pereira Soares, from Fiocruz Bahia, was elected a full member...
Notícias
Data de publicação: 16/12/2020 - 16:31
The Oswaldo Cruz Foundation, through the Institute of Technology in Immunobiologicals (Bio-Manguinhos), signed with the Government of the State of Rio de Janeiro, this Thursday (3/12), the final deed of the land where the Industrial Complex of Biotechnology in Health (Cibs) is being built, in the Industrial District of Santa Cruz, in Rio de Janeiro. The ceremony took place at the Guanabara Palace, the head office of the Rio de Janeiro government...
Notícias

Pages

Back to the topBack